IDIQ: chemistry, manufacturing and controls and related services for development of drug substances
Active Awarded Last action
- Contract number
- 75N95024D00011
- Awardee
-
Polypeptide Laboratories San Diego, LLC UEI KULKXN9J6PF9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 2 $916,000 obligated
Award facts
- Opportunity
-
- Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances Pre-Solicitation · 75N95023R00020 · Posted Apr 20, 2023
- Combined order value
-
- $916,000 Current, with exercised options
- $1,427,000 Potential, with all options
- Last date to order 35% complete
- IDV ceiling 2% used
- $49,713,679.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 15 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute on Drug Abuse awarded a single-award indefinite-delivery contract to Polypeptide Laboratories San Diego, LLC on May 15, 2024, with a ceiling value of $49,713,679 for chemistry, manufacturing, and controls (CMC) and related services for development of drug substances. Performance runs through May 14, 2031. No set-aside applies.
The contract originated from a pre-solicitation posted April 20, 2023, with a proposal due date of May 5, 2023. Work encompasses peptide synthesis, process development, manufacturing, testing, analytical support, and supply chain services for preclinical and IND-enabling studies across therapeutic research domains. Place of performance is in San Diego, California. This vehicle is structured under the National Center for Advancing Translational Sciences (NCATS) Chemistry, Manufacturing, and Controls and Related Services program for Development of Drug Substances.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Manufacture of GMP batch H105A peptide | National Institute on Drug Abuse (NIH) | $601,000 | |
| Process development and manufacture of AZM152 | National Institute on Drug Abuse (NIH) | $315,000 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N95024D00011?
75N95024D00011 was awarded to Polypeptide Laboratories San Diego, LLC by National Institute on Drug Abuse (National Institutes of Health) on May 15, 2024.
How much is contract 75N95024D00011 worth?
Orders under 75N95024D00011 have obligated $916,000. Their combined potential value, with all options, is $1,427,000. 75N95024D00011's own ceiling is $49,713,679.
How many orders have been placed under contract 75N95024D00011?
2 orders have been placed under 75N95024D00011, the latest on September 17, 2026.
Who can order from contract 75N95024D00011?
75N95024D00011 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N95024D00011 part of a contract vehicle?
Yes. 75N95024D00011 is part of NCATS Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances.
Was contract 75N95024D00011 competed?
The extent of competition for 75N95024D00011 was full and open competition. The government received 15 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV